Experimental, early-stage drug aims to restore hearing
Tens of thousands of Americans experience sudden hearing loss each year. Now, a biotech company called Frequency Therapeutics is hoping to be the first to make it to market with a drug it claims will use patients' own biology to restore what was lost. CBS News national correspondent Jericka Duncan reports.